News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Elisa Agostinetto: The results of our translational research project on lobular breast cancer at BSMO25
Elisa Agostinetto/X
Feb 3, 2025, 14:07

Elisa Agostinetto: The results of our translational research project on lobular breast cancer at BSMO25

Elisa Agostinetto,

“It has been a pleasure to present the results of our translational research project on lobular breast cancer awarded with a Gilead Sciences grant at BSMO25 in the beautiful Bruges. Thanks to Evandro de Azambuja and all amazing colleagues and friends!”

Elisa Agostinetto: The results of our translational research project on lobular breast cancer at BSMO25

Breast Cancer BSMO25 cancer Elisa Agostinetto Evandro de Azambuja OncoDaily Oncology
Special Coverage
Opinion
Feb 3, 2025, 14:07
Daniel Heng: Treatment free survival is becoming an important endpoint in different mRCC treatments
Blog
Feb 3, 2025, 14:07
Elisa Agostinetto: The results of our translational research project on lobular breast cancer at BSMO25
Blog
Feb 3, 2025, 14:01
Vivek Subbiah: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Blog
Feb 3, 2025, 13:59
Talha Badar: Quick overview on Ph-like Acute Lymphoblastic Leukemia
Blog
Feb 3, 2025, 13:57
Ezra Cohen: Benefit of adding cetuximab adjuvantly was seen only in HPV negative cancers
Blog
Feb 3, 2025, 13:54
Register to attend the EHA-EBMT 7th European CAR T-cell Meeting
Blog
Feb 3, 2025, 13:51
4 questions for mathematical oncologist Heiko Enderling - MD Anderson Cancer Center
Blog
Feb 3, 2025, 13:46
Özcan Met: The first patient with melanoma received TILs edited with non-viral CRISPR technology
Blog
Feb 3, 2025, 13:44
Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer
Insight
Feb 3, 2025, 13:12
Supriya Peshin: Bosutinib-induced pleural effusion - class effect and cross-intolerance to all TKIs
Opinion
Feb 3, 2025, 13:10
Gustavo Viani: Does acute toxicity predict late toxicity in prostate radiotherapy?
Blog
Feb 3, 2025, 13:06
Stephen V Liu: Grateful for the chance to learn from the top lung cancer experts at ITCD2025